[´Ý±â X]

ȸ»ç¼Ò°³ ±¤°í¹®ÀÇ Áñ°Üã±â
·Î±×ÀΠȸ¿ø°¡ÀÔ ID/PWã±â
Çùȸ¼Ò½Ä Çмú/ÇÐȸ º¸°ÇÁ¤Ã¥ Á¦¾à/À¯Åë ´Üü/º´¿ø ÀÇ·á±â±â ±â´É¼º½Äǰ ÇØ¿Ü¼Ò½Ä
 
ȸ¿ø°¡ÀÔ ID/PWã±â
±â»ç°Ë»ö
2026-04-06,09:59(am)





¼ºÀκ´ ¿øÀΰú ¿¹¹æ
¼ºÀκ´ ¿îµ¿¿ä¹ý
¼ºÀκ´°ú ½Ä»ýȰ
¼ºÀκ´ Çѹæ¿ä¹ý
µ¥½ºÅ© Ä®·³
´ç´¢º´ Ŭ¸®´Ð
°íÇ÷¾Ð Ŭ¸®´Ð µî
¼ºÀκ´ ¹¯°í´äÇϱâ
¹Ú´Þȸ ¼öÇÊ ¸±·¹ÀÌ
À¯ÇüÁر³¼ö Æ÷·³
±èö¼ö¿øÀå Æ÷·³
¾È¿õ½Ä±³¼ö Æ÷·³

Çѵ¶, ¹ÎÁêºñ ¼Ò¼º ¸²ÇÁÁ¾ ÀûÀÀÁõ È®´ë
Çѵ¶ÀÇ ¸é¿ªÇ×¾ÏÁ¦ ¡®¹ÎÁêºñ¡¯°¡ 3¿ù 24ÀÏ ½ÄǰÀǾàǰ¾ÈÀüó·ÎºÎÅÍ ÇÑ °¡Áö ÀÌ»óÀÇ Àü½Å¿ä¹ýÀ» ¹ÞÀº Àç¹ß¼º ¶Ç´Â ºÒÀÀ¼º ¼ÒÆ÷¼º ¸²ÇÁÁ¾(Grade 1-3a) ¼ºÀΠȯÀÚ¿¡¼­ ·¹³¯¸®µµ¸¶ÀÌµå ¹× ¸®Åö½Ã¸¿°ú º´¿ë¿ä¹ýÀ¸·Î ÀûÀÀÁõÀ» Ãß°¡ ½ÂÀι޾Ò..
Çѱ¹¾Öºêºñ-¼­¿ï´ëº´¿ø, Ç×¾ÏÁ¦ °³¹ß Çù·Â
Çѱ¹¾Öºêºñ´Â Áö³­ 2ÀÏ ¼­¿ï´ëÇб³º´¿ø°ú ¾ÖºêºñÀÇ P1PER(Phase 1 Partnerships for Excellence in Research) ³×Æ®¿öÅ©¸¦ ÅëÇØ Ç×¾ÏÁ¦ Á¶±â °³¹ßÀ» °¡¼ÓÇϱâ À§ÇØ Áö¼ÓÇØ¼­ Çù·ÂÇÑ´Ù°í ¹àÇû´Ù. Çѱ¹¾Öºêºñ °­¼Ò¿µ ´ëÇ¥ÀÌ»ç´Â ¼­¿ï..
Áö¾¾¾¾¿¤, VisMederi¿Í ±Û·Î¹ú ¹é½Å Çù·Â °­È­
±Û·Î¹ú ÀÓ»ó½ÃÇè °ËüºÐ¼® ±â°ü Áö¾¾¾¾¿¤ÀÌ ¹Ì±¹ ¿ö½ÌÅÏ D.C.¿¡¼­ ¿­¸° World Vaccine Congress 2026 (WVC 2026) ÇöÀå¿¡¼­ À¯·´ ¹ÙÀÌ¿ÀºÐ¼® Àü¹®±â¾÷ VisMederi S.r.l(ºñ½º¸Þµ¥¸® À¯ÇÑȸ»ç, ÀÌÇÏ VisMederi)¿Í ¾÷¹«Çù¾à(ÀÌÇÏ MOU)À» ..

Çѱ¹¿À°¡³í, ÇÁ·ÎÆä½Ã¾Æ 25³â ¿©Á¤ ¾Ë·Á 03/19 11:48
'Çѱ¹ ·Î·¹¾Ë-À¯³×½ºÄÚ ¿©¼º°úÇÐÀÚ»ó' °ø¸ð 03/19 11:36
´ë¿õÁ¦¾à, '½ºÅ亸Ŭ·Î' ±¹³» ½ÃÀå Ãâ½Ã 03/19 11:34
Çѹ̾àǰ-»ï¼º¹ÙÀÌ¿À¿¡Çǽº, °ñ´Ù°øÁõ Ä¡·áÁ¦ °øµ¿ ÆÇ¸Å 03/19 11:30
KRPIA, ⸳ 25Áֳ⠱â³ä ½½·Î°Ç °ø¸ðÀü ¼º·á 03/18 14:19
¼¼ºê¶õ½º¡¤À̳ëÅ¥ºê ¹ÙÀÌ¿ÀÇコÄÉ¾î °ø¸ð 03/18 14:13
'¸°ÆÄÀÚ' ³­¼Ò¾Ï Çã°¡ 10ÁÖ³â ÀÎÆ÷±×·¡ÇÈ °ø°³ 03/18 14:10
½ÃÁö¸ÞµåÅØ, ÃÖ¼Òħ½À ôÃß¼ö¼ú Çõ½Å °¡¼Ó 03/18 14:06
'³×¼öÆÄ¸³', FDA Èñ±ÍÀǾàǰ ÁöÁ¤ ½ÂÀÎ 03/18 13:59
´ë¿øÁ¦¾à, Á¤¸Æ¼øÈ¯°³¼±Á¦ '´ºº£ÀÎ' ¸®´º¾ó 03/17 12:13
¸ÖÃ÷ ¿¡½ºÅׯ½½º ÄÚ¸®¾Æ, MEX ½ÉÆ÷Áö¾ö ¼º·á 03/17 12:10
À¯ºñÄɾî, AI ±â¼ú Á¢¸ñÇÑ ÀÇ·á ȯ°æ Á¦½Ã 03/17 12:07
ÈÞÁ©, ±Û·Î¹ú º¸¾È °æÀï·Â °­È­ 03/17 12:05
Áö¾¾¼¿, CMC Àü·«ÄÁ¼³ÆÃ »ç¾÷¼öÇà±â°ü ¼±Á¤ 03/17 12:02
ÆÄ·Î½º¾ÆÀ̹ÙÀÌ¿À, ±Û·Î¹ú ±â¼ú ÀÌÀü º»°Ý ÃßÁø 03/17 12:00
LGÈ­ÇÐ, 'Á¦¹Ì±Û·Î' ´©ÀûÆÇ¸Å 1Á¶¿ø µ¹ÆÄ 03/17 11:58
Çѱ¹³ë¹ÙƼ½º, À¥µå¶ó¸¶ 'º¸ÅëÀÇ ³¯' °ø°³ 03/14 13:15
Çѵ¶, Å׳ڸ®¾Æ Ãâ½Ã 10ÁÖ³â ½ÉÆ÷Áö¾ö °³ÃÖ 03/14 13:13
Çѱ¹¾Æ½ºÆ®¶óÁ¦³×Ä«, ³­¼Ò¾Ï ȯÀÚ ÀÀ¿ø Ä·ÆäÀÎ ÁøÇà 03/14 13:11
»ç³ëÇÇ 'µàÇÇÁ¨Æ®', COPD ÀûÀÀÁõ È®´ë ½ÂÀÎ 03/14 13:07
GC³ì½ÊÀÚ, Tdap ¹é½Å ÀÓ»ó 1/2»ó ½Ä¾àó ½ÂÀÎ 03/14 13:03
Á¦À̾ØÇǸ޵ð, Ŭ¶ó¿ìµå Çõ½Å ¼Ö·ç¼Ç ¼Ò°³ 03/14 12:53
Ç®¹«¿ø, '³ÝÁ¦·Î(Net Zero) ½Ã½ºÅÛ' ±¸Ãà 03/14 12:51
BDÄÚ¸®¾Æ, ÃÖ÷´Ü À¯¼¼Æ÷ ºÐ¼®±â¼ú °øÀ¯ 03/14 12:49
¾ÏÁ¨ÄÚ¸®¾Æ, ºí¸°»çÀÌÅä ÀûÀÀÁõ È®´ë Á¶¸í 03/13 12:13
Çѱ¹¿À°¡³í-KNAPS, Çï½Ã ¿¡ÀÌ¡ Çù·Â 03/13 12:08
Çѵ¶-´ÚÅÍ´ÙÀ̾, ´ç´¢º´°ú ºñ¸¸ °ü¸® Çù·Â 03/13 12:06
ÀüÀ̼º ´ëÀå¾Ï Ä¡·áÁ¦ 'ÇÁ·çÀÚŬ¶ó' Çã°¡ 03/13 12:02
¹êƼºê, ÄáÆÏ °ü¸® Á߿伺 °­Á¶ 03/13 12:00
¼ö¼®, Áö¿ª»çȸ ³ª´® ½Çõ 03/12 12:53
óÀ½À¸·Î  51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60   ³¡À¸·Î
¹ÚÇü¼® ¿¬¼¼¾Ïº´¿ø À¯..
"Æò¼Ò À¯¹æ¾Ï ÀÚ°¡°ËÁø ²Ä²ÄÈ÷ Çϼ¼¿ä" 1¡­2§¯ ÀÛÀº ¸Û¿ï..
ÁøÀ±Å ±³¼ö, ¼ÒÈ­±â¾Ï¿¬±¸ÇÐȸ ÀÌ»çÀå ÃëÀÓ
±èÁ¤¿ì ±³¼ö, 34´ë ´ëÇѰßÁÖ°üÀýÇÐȸÀå ÃëÀÓ
°¡Å縯Áß¾ÓÀÇ·á¿ø ½ÅÀÓ ÁÖ¿ä º¸Á÷ÀÚ
¼­¿ï¼º¸ð, °­Á÷¼º ôÃß¿° ¹«·á°Ç°­°­ÁÂ
¼­¿ï¼º¸ðº´¿ø, ³úÁ¹Áß ¹«·á°­ÁÂ
LGÈ­ÇÐ, ¼ºÁ¶¼÷Áõ Ä¡·áÁ¦ '·çÇÁ¿ø' Ãâ½Ã
LGÈ­ÇÐÀÌ ¼Ò¾Æ ģȭÇü ¼ºÁ¶¼÷Áõ Ä¡·áÁ¦¸¦ »õ·Ó°Ô ¼±º¸ÀδÙ. ..

 

2025³â Áö¿ª»çȸ°Ç°­Á¶»ç..
Áö¿ª ÇʼöÀÇ·á 175°³ Æ÷°ý..
ÀÇ·á°³Çõ 2Â÷ ½ÇÇà ¹æ¾È
¼­¿ï½Ã µ¿ÀÛ±¸ µ¿ÀÛµ¿ 102 - 31 ¹øÁö ȯ3ºôµù 402È£ / ÀüÈ­: 02-594-5906~8 / FAX: 02-594-5901
Copyrights (c) 2004 cdpnews.co.kr All rights reserved